Solve is hosting the Hope Biosciences Research Foundation (HBRF) for a webinar on Thursday, May 25 at 10AM PT. HBRF has conducted three FDA-authorized studies in mesenchymal cell therapy for COVID-19 prevention and treatment, and two studies in Long Covid.
Join Solve President Oved Amitay and HBRF founder Donna Chang for a comprehensive discussion of findings and more information about a Long Covid study that is currently enrolling, as well as the potential for future studies in ME/CFS.
No one should suffer alone. Solve is helping millions of people with ME/CFS, Long Covid and other post-infection diseases. Join us today and your gift will be matched! All gifts made by November 30 will be matched up to $300,000! Help us make breakthroughs possible.